행사/교육
[프로메가 e-seminar] Use of ADCC Reporter Bioassays in Influenza Vaccine Development
- 등록일2016-05-03
- 조회수5943
- 구분 국내
- 행사교육분류 행사
-
주관기관
프로메가 코리아
-
행사장소
e-seminar
-
행사기간
2016-05-11
- 원문링크
-
첨부파일
[프로메가 Webinar]
2016년 5월 10일 오후 1시
Use of ADCC Reporter Bioassays in Influenza Vaccine Development
Increasing evidence suggests that antibody-dependent cellular cytotoxicity (ADCC) plays a significant role in antibody-mediated protection and control of viral infection. For influenza in particular, it is becoming increasingly clear that an important in vivo effector function of broadly neutralizing antibodies (bnAbs) includes Fc receptor-mediated ADCC.
This webinar will highlight the development of a novel influenza vaccine that induces bnAbs targeting the HA stem and the role of ADCC in protective immunity. Specifically, this webinar will include:
The development of a stable trimeric influenza HA stem as a broadly protective immunogen
The role of ADCC as an important bnAb MOA
Application of a novel ADCC reporter bioassay to assess bnAb MOA
Best practices in ADCC reporter bioassay setup, optimization and application
This presentation will be of interest to researchers involved in vaccine or biologics drug development and manufacture.
Attendees will have an opportunity to chat live with Janssen Pharmaceutical and Promega experts during the webinar presentation.
...................(계속)
☞ 자세한 내용은 내용바로가기 또는 첨부파일을 이용하시기 바랍니다.